DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: LEMTRADA (Campath, alemtuzumab)
       *****************************************************
       #Post#: 2490--------------------------------------------------
       Alemtuzumab under scrutiny because of risk of stroke in some
       patients with MS
   DIR By: agate
       Date: April 26, 2019, 11:15 am
       ---------------------------------------------------------
       The Lancet (April 27, 2019) contains an article on this topic
       though there is no easy access to it. However, another article
       (from Lancet Neurology, February 15) (see link below) explains
       the situation under discussion:
       --- Quote ---
       > Reports of stroke in patients having taken alemtuzumab for
       multiple sclerosis prompt a safety review by the European
       Medicines Agency.
       --- End Quote ---
       The February 15 article, "Intracerebral hemorrhage during
       alemtuzumab administration":
  HTML https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(19)30076-6/fulltext
       *****************************************************
       Page 1 of 1